⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAR News
Pharming Group N.V. ADS, each representing 10 ordinary shares
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (PHAR) And Encourages Stockholders to Reach Out
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pharming Group N.V. (PHAR) And Encourages Shareholders to Connect
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pharming Group N.V. (PHAR) And Encourages Shareholders to Reach Out
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
PHAR
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
globenewswire.com
PHAR
Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
PHAR
Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Pharming Group N.V. (PHAR) And Encourages Investors to Connect
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Stockholders to Inquire about Securities Investigation
accessnewswire.com
PHAR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
PHAR